Precision Medicine Project - Computer modelling of the retinal microvasculature: a move towards personalised management of kidney disease and brain health through improved understanding of vascular dysfunction and injury Supervisor(s): Dr Tom MaGillivray, Dr Ian MacCormick & Prof Miguel O. BernabeuCentre/Institute: Centre for Clinical Brain SciencesBackground:The retina, kidney and brain share similar microvasculature and vasoregulation [1]. Likewise, they are susceptible to microvascular dysfunction that can damage vessel walls and the endothelial cells lining them. This impacts the ability to dilate or constrict and to regulate blood flow. Such structural and functional changes play an important role in the development and progression of chronic kidney disease (CKD) [2] and cerebrovascular small vessel disease ([cSVD], a contributing factor to 45% of dementias and 20% of ischemic strokes) [3]. Using the retina as a proxy for less accessible vessels could improve our understanding of microvascular dysfunction and injury and lead to personalised management of the interconnected risks of kidney disease and brain health. Optical coherence tomography (OCT) provides cross-sectional imaging of the retina and choroid (the dense vascular layer sitting behind the photoreceptors) and fundus photography, ultra-widefield scanning laser ophthalmoscopy, and OCT angiography capture the retinal microvasculature. While there are correlations between measures derived from these images and both CKD and cSVD, the associations are not robust enough to replace current diagnostic methods [4]. New approaches are needed to realise the clinical utility of the retina but also to improve upon existing clinical biomarkers for kidney and brain that only become abnormal after damage has occurred and have limited prognostic capabilities.AimsTo extract superior information about the state of the microvasculature at the back of the eye than has previously been achievable and use this to investigate: (1) detecting and tracking of disease in the kidney and brain, (2) monitoring response to treatment, and (3) predicting patient outcomes.The project will utilise recent technological advancements from our group in processing retinal images as the basis for building novel 3D patient-specific computer models of the microvasculature. It will leverage existing longitudinal multi-modal retinal imaging linked to clinical data that we have previously collected. This includes healthy volunteers (n=250), those with CKD (n=500) and those with CKD who have received a kidney transplant and therefore their kidney function has returned to a healthy level (n=250). Clinical biomarkers of CKD (estimated glomerular filtration rate [eGFR] and proteinuria) are also available. Additionally, a mid-life cohort (n=180) currently returning for a third wave of tests and who are currently in good health but with low/medium/high risk of dementia in later life based on ApoE status, family history, and cardiovascular risk factors. Plus, MRI derived measurements of cSVD (i.e., lacunes, microbleeds, white matter hyperintensities, and enlarged perivascular spaces) and cognitive tests.The student will develop the computational processes for re-creating the microvascular anatomy contained within image data for a person and then use these detailed models to examine geometric differences (that might be missed by conventional retinal image analysis) between patient groups as well as longitudinal changes for individuals in response to disease progression (i.e., worsening eGFR/proteinuria; increase in MRI markers of cSVD) and treatment (e.g., therapies to reduce systemic and renal inflammation or vasoactive medications). They will also experiment with deriving boundary conditions and simulating blood flow velocities and vessel wall dynamics to generate a physiological dimension to the computer modelling and investigate what additional information this reveals about changes to microvascular health in relation to CKD and cSVD. The student will explore trajectories of change in the retinas and use machine learning classification techniques (e.g., logistic regression, decision trees, deep neural networks) to attempt the stratification of patients/groups. Finally, the project will look at predicting outcomes such as associated cardiovascular disease events (i.e., myocardial infarction, stroke, heart failure and cardiovascular mortality) and deteriorating brain health (e.g., increasing lesion volume on MRI, decreasing cognitive scores) to contribute to future personalised risk-based intervention.Training outcomesProject-specific training/experience will be provided in:Retinal imaging and state-of-the-art computational analysisMachine learning-based classification approachesKidney disease, brain health, and clinical biomarkers of CKD and cSVDComputer modelling of the microvasculature and blood flowPrediction strategies for modelling patient outcomesReferencesAbbas K, et al. A Simple Review of Small Vessel Disease Manifestation in the Brain, Retina, and Kidneys. J Clin Med. 2022 Sep 22;11(19):5546.Li, S., Wang, F. & Sun, D. The renal microcirculation in chronic kidney disease: novel diagnostic methods and therapeutic perspectives. Cell Biosci 11, 90 (2021).Inoue Y, et al. Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer's disease. Mol Neurodegener. 2023 Jul 11;18(1):46Balmforth C, van Bragt JJMH, Ruijs T, et al. Chorioretinal thinning in chronic kidney disease links to inflammation and endothelial dysfunction. JCI Insight. 2016;1(20):e89173Apply NowClick here to Apply NowThe deadline for 25/26 applications is Monday 13th January 2025Applicants must apply to a specific project. Please ensure you include details of the project on the Recruitment Form below, which you must submit to the research proposal section of your EUCLID application. Please ensure you upload as many of the requested documents as possible, including a CV, at the time of submitting your EUCLID application. Document Precision Medicine Recruitment Form (878.42 KB / DOCX) Q&A SessionsSupervisor(s) of each project will be holding a 30 minute Q&A session in the first two weeks of December. If you have any questions regarding this project, you are invited to attend the session on Wednesday 11th December at 2pm GMT via Microsoft Teams. Click here to join the session. This article was published on 2024-11-04